Possibilities and Difficulties of Treatment in the Case of a Pregnant Patient with Primary Mediastinal Large B-cell Lymphoma

1. Swerdlow S, Campo E, Harris N. WHO Classification of Tumours of hematopoietic and Lymphoid Tissues, 4th edition, Lyon, France, IARC Press, 2008.Search in Google Scholar

2. Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non Hodgkin’s lymphoma in pregnancy. Hematologica. 2007;92(09):1230-37.10.3324/haematol.1109717666365Search in Google Scholar

3. Smith SM, Vose JM. Treatment approach to diffuse large B-cell lymphomas. In O’Brien S., Vose J.M., Kantarjian H.M. Management of Hematologic Malignancies. Cambridge University Press, 2011:286-307.10.1017/CBO9780511781926.016Search in Google Scholar

4. Baldissera RC, Nucci M, Vigorito AC. Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non- Hodgkin's lymphoma patients: a prospective randomized GEMOH report. Acta Haematol. 2006;115:15-21.10.1159/00008946016424644Search in Google Scholar

5. Sieniawski M, Staak O, Glossmann JP. Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma. Ann Hematol. 2007;86:107-15.10.1007/s00277-006-0210-517103169Search in Google Scholar

6. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood. 2007;110:3507-16.10.1182/blood-2007-06-09723817709603Search in Google Scholar

7. Branson K, Chopra R, Kottaridis PD- Role of nonmyeloablative allogeneic stem-cell transplantation in patients with lymphoproliferative malignancies. J Clin Oncol. 2002;20:4022-31.10.1200/JCO.2002.11.08812351600Search in Google Scholar